The Centers for Disease Control and Prevention is assisting in a on the use of contaminated non-sterile ultrasound gel for ultrasound-guided percutaneous procedures. Reports of Paraburkholderia fungorum detected in blood cultures from patients across multiple health care facilities prompted the investigation, and the CDC said it was aware of 40 confirmed cases of the bacteria in four states and two other countries as of May 8. Tests found at least two contaminated products under the MediChoice and ClearImage brands that are manufactured by NEXT Medical Products Company. The CDC provided a series of recommendations for health care providers to ensure patient safety and prevent potential outbreaks.

Related News Articles

Headline
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in鈥
Headline
The Centers for Medicare & Medicaid Services Feb. 14 announced it ceased implementation of the Hospice Special Focus Program so the agency can further鈥
Headline
The AHA released an infographic Feb. 13 highlighting the many ways hospitals and health systems advance health and support their communities. In 2023, U.S.鈥
Headline
President Trump Feb. 13 signed an executive order establishing the Make America Healthy Again Commission, to be chaired by Department of Health and Human鈥
Headline
In this new 鈥淐aring for Our Kids鈥 episode, David Wagner, pediatric psychologist at Oregon Health and Science University, discusses the Novel Interventions in鈥
Chairperson's File
From making pizzas to leading an integrated health system, Tina Freese Decker鈥檚 career has focused on a connection to people and serving others. She is鈥